| Title | Date Published | Source |
|---|---|---|
| Recall of a Single Lot of Actavis / Catalent Bupropion Extended-Release Tablets 150 mg | 2009-Oct-25 | FDA |
| New Boxed Warning For Bupropion (marketed as Zyban, Wellbutrin, and generics) | 2009-Jul-01 | FDA |
| New Antidepressant Guide for Patients | 2009-Jan-12 | FDA |
| Recall of selected 300mg tablets | 2008-Mar-27 | FDA |
DISCLAIMER: iGuard is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.
